Skip to main content
SpringerLink
Log in

Urticaria and Drug-Induced Eruptions

  • Chapter
  • First Online:
Skin Disorders in Migrants

  • 324 Accesses

Abstract

The diseases described in this chapter are caused by allergic reactions to drugs or food. No other dermatologic pathologies present with such a wide range of clinical features due to both individual idiosyncrasies and various triggering agents.

Accordingly, urticaria-angioedema and drug-induced cutaneous reactions are taken into consideration here.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Beltrani VS. Urticaria: reassessed. Allergy Asthma Proc. 2004;25(3):143–9.

    PubMed  Google Scholar 

  2. Brancaccio RR, Alvarez MS. Contact allergy to food. Dermatol Ther. 2004;17(4):302–13.

    Article  Google Scholar 

  3. Cancian M, Bortolati M, Fagiolo U. Urticaria and angioedema. Ann Ital Med Int. 2003;18(1):16–23.

    PubMed  Google Scholar 

  4. Caproni M, Volpi W, Giomi B, et al. Chronic idiopathic and chronicautoimmune urticaria: clinical and immunopathological features of 68 subjects. Acta Derm Venereol. 2004;84(4):288–90.

    Article  Google Scholar 

  5. Charlesworth EN. Urticaria and angioedema. Allergy Asthma Proc. 2002;23(5):341–5.

    PubMed  Google Scholar 

  6. Clarke P. Urticaria. Aust Fam Physician. 2004;33(7):501–3.

    PubMed  Google Scholar 

  7. Grattan CE, Sabroe RA, Greaves MW. Chronic urticaria. J Am Acad Dermatol. 2002;46(5):645–57. quiz 657–660.

    Article  Google Scholar 

  8. Huggins JL, Looney RJ. Alergen immunotherapy. Am Fam Physician. 2004;70(4):689–96.

    PubMed  Google Scholar 

  9. Mansueto P, Rizzo M, Di Fede G, et al. Urticaria and angioedema. An internal disorder with cutaneous manifestation. Recenti Prog Med. 2004;95(6):325–32.

    PubMed  Google Scholar 

  10. Nettis E, Pannofino A, D’Aprile C, et al. Clinical and aetiological aspects in urticaria and angio-oedema. Br J Dermatol. 2003;148(3):501–6.

    Article  CAS  Google Scholar 

  11. Tan EK, Grattan CE. Drug-induced urticaria. Expert Opin Drug Saf. 2004;3(5):471–84.

    Article  CAS  Google Scholar 

  12. Tedeschi A, Airaghi L, Lorini M, Asero R. Chronic urticaria: a role for newer immunomodulatory drugs? Am J Clin Dermatol. 2003;4(5):297–305.

    Article  Google Scholar 

  13. Kulthanan K, Tuchinda P, Chularojanamontri L, et al. Clinical practice guideline for diagnosis and management of urticaria. Asian Pac J Allergy Immunol. 2016;34(3):190–200.

    PubMed  Google Scholar 

  14. Kowalski ML, Woessner K, Sanak M. Approaches to the diagnosis and management of patients with a history of nonsteroidal anti-inflammatory drug-related urticaria and angioedema. J Allergy Clin Immunol. 2015;136(2):245–51. https://doi.org/10.1016/j.jaci.2015.06.021.

    Article  CAS  PubMed  Google Scholar 

  15. Spickett G. Urticaria and angioedema. J R Coll Physicians Edinb. 2014;44(1):50–4. https://doi.org/10.4997/JRCPE.2014.112.

    Article  CAS  PubMed  Google Scholar 

  16. Hon KLE, Leung AKC, Ng WGG, Loo SK. Chronic Urticaria: an overview of treatment and recent patents. Recent Pat Inflamm Allergy Drug Discov. 2019;13:27. https://doi.org/10.2174/1872213X13666190328164931.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Dewachter P, Kopac P, Laguna JJ, et al. Anaesthetic management of patients with pre-existing allergic conditions: a narrative review. Br J Anaesth. 2019;123:e65–81. https://doi.org/10.1016/j.bja.2019.01.020.

    Article  PubMed  Google Scholar 

  18. Doña I, Jurado-Escobar R, Perkins JR, et al. Eicosanoid mediator profiles in different phenotypes of nonsteroidal anti-inflammatory drug-induced urticaria. Allergy. 2019;74:1135–44. https://doi.org/10.1111/all.13725.

    Article  CAS  PubMed  Google Scholar 

  19. Kanani A, Betschel SD, Warrington R. Urticaria and angioedema. Allergy Asthma Clin Immunol. 2018;14(Suppl 2):59. https://doi.org/10.1186/s13223-018-0288-z.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Westby EP, Lynde C, Sussman G. Chronic urticaria: following practice guidelines. Skin Therapy Lett. 2018;23(3):1–4.

    CAS  PubMed  Google Scholar 

  21. Cicardi M, Suffritti C, Perego F, Caccia S. Novelties in the diagnosis and treatment of angioedema. J Investig Allergol Clin Immunol. 2016;26(4):212–21.; quiz two pages after page 221. https://doi.org/10.18176/jiaci.0087.

    Article  CAS  PubMed  Google Scholar 

  22. Hsieh FH. Year in review: urticaria and angioedema. Ann Allergy Asthma Immunol. 2015;114(3):166–7. https://doi.org/10.1016/j.anai.2014.12.001.

    Article  PubMed  Google Scholar 

  23. Brown SD, Landry FJ. Recognizing, reporting, and reducing adverse drug reactions. South Med J. 2001;94:370–3.

    Article  Google Scholar 

  24. Krautheim AB, Jermann TH, Bircher AJ. Chlorhexidine anaphylaxis: case report and review of the literature. Contact Dermatitis. 2004;50(3):113–6.

    Article  CAS  Google Scholar 

  25. Kuechler PC, Britschgi M, Schmid S, et al. Cytotoxic mechanisms in different forms of T-cell-mediated drug allergies. Allergy. 2004;59(6):613–22.

    Article  CAS  Google Scholar 

  26. Neugut AI, Ghatak AT, Miller RL. Anaphylaxis in the United States: an investigation into its epidemiology. Arch Intern Med. 2001;161:15–21.

    Article  CAS  Google Scholar 

  27. Wilkerson A, Smoller B. The pustular disorders. Semin Cutan Med Surg. 2004;23(1):29–38.

    Article  Google Scholar 

  28. Lee EY, Teitelbaum D, Chiam M, Vadas P. Characterization of patients withIbuprofen hypersensitivity. Int Arch Allergy Immunol. 2019;178(2):177–81. https://doi.org/10.1159/000494388.

    Article  CAS  PubMed  Google Scholar 

  29. Simon D. Recent advances in clinical allergy and immunology. Int Arch Allergy Immunol. 2018;177(4):324–33. https://doi.org/10.1159/000494931.

    Article  CAS  PubMed  Google Scholar 

  30. Schatz M, Sicherer SH, Zeiger RS. The journal of allergy and clinical immunology: in practice 2017 year in review. J Allergy Clin Immunol Pract. 2018;6(2):328–52. https://doi.org/10.1016/j.jaip.2017.12.016.

    Article  PubMed  Google Scholar 

  31. Castells MC. Drug allergy: phenotypes, endotypes, and biomarkers. J Allergy Clin Immunol Pract. 2017;5(3):626–7. https://doi.org/10.1016/j.jaip.2017.03.026.

    Article  PubMed  Google Scholar 

  32. Zalewska-Janowska A, Spiewak R, Kowalski ML. Cutaneous manifestation of drug allergy and hypersensitivity. Immunol Allergy Clin North Am. 2017;37(1):165–81. https://doi.org/10.1016/j.iac.2016.08.006.

    Article  PubMed  Google Scholar 

  33. Gagne JJ, Han X, Hennessy S, et al. Successful comparison of US food and drug administration sentinel analysis tools to traditional approaches in quantifying a known drug-adverse event association. Clin Pharmacol Ther. 2016;100(5):558–64. https://doi.org/10.1002/cpt.429.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Indradat S, Veskitkul J, Pacharn P, et al. Provocation proven drug allergy in Thai children with adverse drug reactions. Asian Pac J Allergy Immunol. 2016;34(1):59–64. https://doi.org/10.12932/AP0601.34.1.2016.

    Article  CAS  PubMed  Google Scholar 

  35. Marzano AV, Borghi A, Cugno M. Adverse drug reactions and organ damage: the skin. Eur J Intern Med. 2016;28:17–24. https://doi.org/10.1016/j.ejim.2015.11.017.

    Article  CAS  PubMed  Google Scholar 

  36. Waldman R, Whitaker-Worth D, Grant-Kels JM. Cutaneous adverse drug reactions: kids are not just little people. Clin Dermatol. 2017;35(6):566–82. https://doi.org/10.1016/j.clindermatol.2017.08.007.

    Article  PubMed  Google Scholar 

  37. Young JWS, Shear NH. Cutaneous drug reactions in the elderly. Drugs Aging. 2017 Sep;34(9):655–72. https://doi.org/10.1007/s40266-017-0483-5.

    Article  CAS  PubMed  Google Scholar 

  38. Kiepurska N, Paluchowska E, Owczarek W, et al. The direct costs of drug-induced skin reactions. Ann Agric Environ Med. 2017;24(2):190–3. https://doi.org/10.5604/12321966.1235168.

    Article  PubMed  Google Scholar 

  39. Duong TA, Valeyrie-Allanore L, Wolkenstein P, Chosidow O. Severe cutaneousadverse reactions to drugs. Lancet. 2017;390(10106):1996–2011. https://doi.org/10.1016/S0140-6736(16)30378-6.

    Article  CAS  PubMed  Google Scholar 

  40. Kaufman G. Adverse drug reactions: classification, susceptibility and reporting. Nurs Stand. 2016;30(50):53–63. https://doi.org/10.7748/ns.2016.e10214.

    Article  PubMed  Google Scholar 

  41. Graudins LV, Ly J, Trubiano J, Aung AK. More than skin deep. Ten yearfollow-up of delayed cutaneous adverse drug reactions (CADR). Br J Clin Pharmacol. 2016;82(4):1040–7. https://doi.org/10.1111/bcp.13030.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Chung WH, Wang CW, Dao RL. Severe cutaneous adverse drug reactions. J Dermatol. 2016;43(7):758–66. https://doi.org/10.1111/1346-8138.13430.

    Article  CAS  PubMed  Google Scholar 

  43. Hoetzenecker W, Nägeli M, Mehra ET, et al. Adverse cutaneous drug eruptions: current understanding. Semin Immunopathol. 2016;38(1):75–86. https://doi.org/10.1007/s00281-015-0540-2.

    Article  CAS  PubMed  Google Scholar 

  44. Smith W. Adverse drug reactions—allergy? Side-effect? Intolerance? Aust Fam Physician. 2013;42(1–2):12–6.

    PubMed  Google Scholar 

  45. Wu W, Liu D, Li K, et al. Post-marketing safety surveillance for inactivated and live-attenuated Japanese encephalitis vaccines in China, 2008-2013. Vaccine. 2017;35(29):3666–71. https://doi.org/10.1016/j.vaccine.2017.05.021.

    Article  PubMed  Google Scholar 

  46. Narwaney KJ, Breslin K, Ross CA, et al. Vaccine adverse events in a safety net healthcare system and a managed care organization. Vaccine. 2017;35(9):1335–40. https://doi.org/10.1016/j.vaccine.2017.01.017.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Seligman SJ, Casanova JL. Yellow fever vaccine: worthy friend or stealthy foe? Expert Rev Vaccines. 2016;15(6):681–91. https://doi.org/10.1080/14760584.2016.1180250.

    Article  CAS  PubMed  Google Scholar 

  48. Esposito S, Prada E, Lelii M, Castellazzi L. Immunization of children with secondary immunodeficiency. Hum Vaccin Immunother. 2015;11(11):2564–70. https://doi.org/10.1080/21645515.2015.1039208.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Rosenblatt AE, Stein SL. Cutaneous reactions to vaccinations. Clin Dermatol. 2015;33(3):327–32. https://doi.org/10.1016/j.clindermatol.2014.12.009.

    Article  PubMed  Google Scholar 

  50. Woo EJ. Allergic reactions after egg-free recombinant influenza vaccine: reports to the US vaccine adverse event reporting system. Clin Infect Dis. 2015;60(5):777–80. https://doi.org/10.1093/cid/ciu948.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. San Gallicano Dermatological Institute IRCCS IFO, Rome, Italy

    Aldo Morrone

Authors
  1. Aldo Morrone
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Aldo Morrone .

Editor information

Editors and Affiliations

  1. San Gallicano Dermatological Institute IRCCS IFO, Rome, Italy

    Aldo Morrone

  2. International Foundation for Dermatology, London, UK

    Roderick Hay

  3. Foundation Global Dermatology, Munnekeburen, Friesland, The Netherlands

    Bernard Naafs

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Morrone, A. (2020). Urticaria and Drug-Induced Eruptions. In: Morrone, A., Hay, R., Naafs, B. (eds) Skin Disorders in Migrants. Springer, Cham. https://doi.org/10.1007/978-3-030-37476-1_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-37476-1_14

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-37475-4

  • Online ISBN: 978-3-030-37476-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation